| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 6,900 | 6,900 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| BERKSHIRE HATHAWAY SERIES B NEW | 36,261 | 65,982 |
| BRISTOL MYERS SQUIBB CO | ||
| EXXON MOBIL CORP | 36,139 | 47,990 |
| ABBOTT LABORATORIES | ||
| ABBVIE INC | 34,785 | 40,292 |
| COLGATE-PALMOLIVE CO | 91,184 | 94,855 |
| JOHNSON & JOHNSON | ||
| MEDTRONIC PLC | ||
| MERCK & CO INC | ||
| ORGANON & CO | ||
| TEVA PHARMACEUTICAL IN F | ||
| UNITEDHEALTH GRP INC | 170,830 | 469,611 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| RUSSELL INVT EMERGING MARKETS FUNDS CL S | AT COST | ||
| RUSSELL INVT US SMALL CAP EQUITY INV CL | AT COST | ||
| RUSSELL INVT INTL DEVELOPED MARKETS FUND | AT COST | ||
| RUSSELL INVT CO US STRATEGIC EQUITY FUND | AT COST | ||
| SCHWAB TREASURY OBLIG (SNOXX) | AT COST | 32,000 | 32,000 |
| CIBC ATLAS EQUITY INCOME | AT COST | 43,569 | 47,876 |
| CIBC ATLAS INTERNATIONAL | AT COST | 133,723 | 141,690 |
| CIBC ATLAS MID CAP EQUITY | AT COST | 73,270 | 78,438 |
| VANGUARD MID CAP ETF | AT COST | 159,144 | 172,619 |
| CANGUARD SMALL CAP ETF | AT COST | 84,575 | 96,425 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ADVISORY FEES | 2,810 | 2,810 | ||
| FILING FEES - CHAR 500 | 275 | 275 |